Stem Cell-Derived Exosomes as New Horizon for Cell-Free Therapeutic Development: Current Status and Prospects
Exosomes have come a long way since they were first described in 1981 by Trams et al. as small lipid bilayer-enclosed vesicles of endocytic origin. Their ability to alter cell bioactivity combined with their advancing popularity as disease biomarkers and therapeutic delivery systems has compelled ma...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/86706 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Stem Cell-Derived Exosomes as New Horizon for Cell-Free Therapeutic Development: Current Status and Prospects
- Reprogramming Somatic Cells by Fusion with Embryonic Stem Cells: Present Status and Prospects in Regenerative Medicine
- Harnessing the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Prostate Cancer: Current Insight and Perspective
- Mesenchymal Stem Cell-Derived Exosomes as a New Possible Therapeutic Strategy for Parkinson’s Disease
- Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Treatment
- Emerging Role and Therapeutic Application of Mesenchymal Stem Cell (MSC) and MSC-Derived Exosome in Coronavirus Disease-2019 (COVID-19) Infection
- Stem Cells for Therapy of Eye Diseases: Current Status